Endocrinology

>

The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Latest News

Patient Factors Influence Semaglutide Initiation After Obesity Diagnosis | Image Credit: Boston University
Patient Factors Influence Semaglutide Initiation After Obesity Diagnosis

January 21st 2025

Approximately 2.0% of commercially insured individuals with obesity, but not diabetes, initiated semaglutide within 6 months of diagnosis.

Semaglutide 7.2 mg Exhibits 20.7% Weight Loss in Phase 3b STEP UP Trial | Image Credit: Novo Nordisk
Semaglutide 7.2 mg Displays 20.7% Weight Loss in Phase 3b STEP UP Trial

January 17th 2025

HHS Targets 15 Drugs for Medicare Part D Negotiations, Including Semaglutide | Image Credit: HHS
HHS Targets 15 Drugs for Medicare Part D Negotiations, Including Semaglutide

January 17th 2025

Genetic Determinants of LDL-C Inversely Linked to Type 2 Diabetes Risk | Image Credit: Massachusetts General Hospital
Genetic Determinants of LDL-C Inversely Linked to Type 2 Diabetes Risk

January 15th 2025

Chia-Chih Kuo, APN | Credit: ResearchGate
GLP-1 RAs Provide Greater Hepatic Benefit Than SGLT2is For MASLD, Type 2 Diabetes

January 14th 2025

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP

Thumbnail logo for Diabetes Dialogue podcast
Latest CME Events & Activities
<1
...
147148149150151
© 2025 MJH Life Sciences

All rights reserved.